Andrew Davis is Vice President at Scheer Partners and helps run the scientific real estate practice. Andrew lives in Maryland but assists scientific companies identify, negotiate, and build space in the Biohealth Capital Region, Philadelphia / Greater PA, and Massachusetts.
Emergent BioSolutions to Invest $75 Million in Canton Site and Expand Viral Vector and Gene Therapy Capability
Emergent BioSolutions to Invest $75 Million in Canton Site and Expand Viral Vector and Gene Therapy Capability June 18, 2020 Company acquires property adjacent to its Canton, Massachusetts live viral [….]
Rock Creek Property Group Breaks Ground on BIO at 700 QO October 30, 2019 Rock Creek Property Group (Rock Creek) officially broke ground on its redevelopment of 700 Quince Orchard [….]
New Lab Space Designed to Attract Biotech Talent and Community Opens at 704 Quince Orchard Next Generation Lab Building completes the Gaithersburg Life Sciences Cluster February 6, 2019 When construction [….]
Image Credit: www.utunisphere.com October 1, 2018 The Unisphere Opens in Silver Spring to Grow Transplantable Organs with a Net Zero Carbon Footprint On Friday, September 21st United Therapeutics celebrated the [….]
Paragon Welcomes Employees to New Gene Therapy Manufacturing Facility After a week of persistent rain throughout Maryland, it was blue skies and a perfect 85-degree summer afternoon that marked an [….]